We speculate that the results of the case-control analysis in AD remain preliminary due to the small number of subjects, and further investigation of the GRK5 polymorphisms with a larger and more ethnically diverse population of AD patients is warranted. This evidence concerns the gene GRK5 and Alzheimer disease.